中国网财经11月7日讯 昨日，葛兰素史克 (“GSK”)携重磅疫苗产品再赴进博之约，覆盖带状疱疹、宫颈癌等疾病领域，并举办以“深化医防融合，共筑健康中国”为主题的媒体圆桌活动。

The verdict follows investigations initiated by China's Ministry of Public Security in June 2013. GSKCI will pay a fine of £297 million (3 billion RMB) to the Chinese Government, which will be ...

Meanwhile, here are a few items of interest to help get you on your way. We hope today is manageable and productive. Best of ...

中新网 上海11月5日电 (记者 樊中华 汤彦俊)“进博会让我们外企有了切实的获得感，看得到中国未来发展的确定性。进博会越办越好，企业也越走越快，进博‘溢出效应’是企业感受到的最直接的价值。” ...

Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley ...

GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

I think elections are like pregnancy. … Everyone puts all of the energy into D-day – the birth. We’ve had the gender reveal, but what really, really matters is what happens now and the path ahead.” ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

GSK reported positive results from its phase three ‘DREAMM-7’ trial on Thursday, highlighting a significant overall survival ...